Orphan drug status for Aeterna’s cancer treatment

Orphan drug status for Aeterna’s cancer treatment
European regulators have given orphan drug status to Aeterna Zentaris’ potential ovarian cancer treatment, the Canadian biotechnology company said Monday.

Read more on AP via Yahoo! Finance

More Meth Drug Addiction Info: